IRVINE, Calif., April 8, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a leader in medical devices, today announced that it expects to join the fight against the coronavirus (COVID-19) outbreak by teaming up with MEKICS Co. Ltd, an intensive care unit (ICU) equipment manufacturer, to supply MEKICS's MTV-1000 ICU-grade portable ventilator through BIOLASE's FDA-registered manufacturing facility in California. The MTV-1000 ventilator received FDA authorization for emergency use during the COVID-19 pandemic.
"In this time of global crisis, it is vital that companies come together to support the fight against COVID-19, leveraging every tool available, and that's exactly what we intend to do," said Todd Norbe, CEO of BIOLASE. "Without hesitation, we expect to pivot quickly and leverage our FDA-registered facility for the manufacturing and delivery of the MTV-1000 ventilator and have already received over $10 million in orders. We expect to continue to focus our efforts to quickly ramp up production, with the expectation to double the number of orders over the next few weeks."
BIOLASE has received authorization to manufacture and supply the MTV-1000 ventilator under the FDA Emergency Use Authorization and an exemption from the State of California to operate, market and produce this critically needed product. BIOLASE expects to use its years of experience in manufacturing and distributing FDA-cleared medical equipment to help supply ventilators and support the global backorder on ventilators during the COVID-19 crisis.
The BIOLASE and MEKICS collaboration aims to bring the MTV-1000 to the United States for the first time. The MTV-1000 is a field-tested, ICU-level, portable ventilator that has pressure-control and an internal positive end-expiratory pressure (PEEP) feature, which is often required for COVID-19 patients.
"Collaborating with the team at BIOLASE, who have years of experience manufacturing, marketing and selling medical equipment in the United States, is a great opportunity for us to provide this much-needed product to the U.S. public," said Jong Cheol Kim, CEO for MEKICS. "We are doing our very best to meet the demand of the U.S. market and believe it is an honor to help the American public in any way we can."
MEKICS Co. Ltd. is a medical equipment company based at 21, Sangjiseok-gil, Paju-Si, Gyeonggi-do 10911, Korea with 20 years of experience in manufacturing various respiratory products, including ventilators.
To place an order, please send an email to Stephen Jang at [email protected].
About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed to provide clinically superior, patient-friendly results for many types of common dental procedures compared to those achieved with traditional instruments. BIOLASE has sold over 41,000 laser systems to date in over 80 countries around the world.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, LinkedIn at www.linkedin.com/company/biolase, Instagram at www.instagram.com/waterlase_laserdentistry, and YouTube at www.youtube.com/biolasevideos.
BIOLASE®, Waterlase®, Waterlase iPlus® and Epic Hygiene™ are registered trademarks of BIOLASE, Inc.
SOURCE BIOLASE, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article